IN2014CN04861A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04861A
IN2014CN04861A IN4861CHN2014A IN2014CN04861A IN 2014CN04861 A IN2014CN04861 A IN 2014CN04861A IN 4861CHN2014 A IN4861CHN2014 A IN 4861CHN2014A IN 2014CN04861 A IN2014CN04861 A IN 2014CN04861A
Authority
IN
India
Prior art keywords
factor
sulphonylaminopyrrolidinone
drugs
compounds
processes
Prior art date
Application number
Other languages
English (en)
Inventor
Nathalie Alet
Jean Michel Altenburger
Jean Pascal Herault
Reinhard Kirsch
Gilbert Lassalle
Sergio Mallart
Orts Marie Claire Philippo
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IN2014CN04861A publication Critical patent/IN2014CN04861A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IN4861CHN2014 2011-12-21 2012-12-19 IN2014CN04861A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11306733.4A EP2606893A1 (fr) 2011-12-21 2011-12-21 Dérivés de la sulphonylaminopyrrolidinone, leur préparation et leur application thérapeutique
PCT/EP2012/076224 WO2013092756A1 (fr) 2011-12-21 2012-12-19 Dérivés sulfonylaminopyrrolidinone, préparation et application thérapeutique de ceux-ci

Publications (1)

Publication Number Publication Date
IN2014CN04861A true IN2014CN04861A (fr) 2015-09-18

Family

ID=47428640

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4861CHN2014 IN2014CN04861A (fr) 2011-12-21 2012-12-19

Country Status (18)

Country Link
US (1) US9150544B2 (fr)
EP (2) EP2606893A1 (fr)
JP (1) JP6104936B2 (fr)
KR (1) KR20140106703A (fr)
CN (1) CN104136030B (fr)
AR (1) AR089397A1 (fr)
AU (1) AU2012357123B2 (fr)
BR (1) BR112014014869A2 (fr)
CA (1) CA2859575A1 (fr)
ES (1) ES2559854T3 (fr)
IL (1) IL233238A (fr)
IN (1) IN2014CN04861A (fr)
MX (1) MX347620B (fr)
RU (1) RU2014129787A (fr)
SG (1) SG11201403336QA (fr)
TW (1) TWI568727B (fr)
UY (1) UY34543A (fr)
WO (1) WO2013092756A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
CN104557928B (zh) * 2015-02-14 2016-08-24 佛山市赛维斯医药科技有限公司 一种含二环酰胺结构凝血因子Xa抑制剂、其制备方法及其用途
AR117006A1 (es) * 2018-11-08 2021-07-07 Glaxosmithkline Ip Dev Ltd Compuesto de 1,3-azol sustituido, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento
EP4070658A1 (fr) 2021-04-06 2022-10-12 BIORoxx GmbH Utilisation de composés anticoagulants comme rodenticides
CN113264819A (zh) * 2021-05-25 2021-08-17 都创(上海)医药开发有限公司 一种基于连续流反应技术快速合成3-溴-2-氟苯甲醛的方法
TW202404583A (zh) 2022-06-08 2024-02-01 加拿大商再諾製藥公司 吡啶胺衍生物及其作為鉀通道調節劑之用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4121947A1 (de) * 1991-07-03 1993-01-07 Basf Ag 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
PL333921A1 (en) * 1996-12-13 2000-01-31 Rhone Poulenc Rorer Pharma N-(heteroalkyl)-azaheterocyclyamides of sulphonic acids or other n-(heteroalkyl)-azaheterocyclylamide compounds
US6602864B1 (en) 1996-12-13 2003-08-05 Aventis Pharma Deutschland Gmbh Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds

Also Published As

Publication number Publication date
TWI568727B (zh) 2017-02-01
IL233238A (en) 2016-10-31
EP2606893A1 (fr) 2013-06-26
AU2012357123B2 (en) 2016-12-15
UY34543A (es) 2013-06-28
CA2859575A1 (fr) 2013-06-27
ES2559854T3 (es) 2016-02-16
WO2013092756A1 (fr) 2013-06-27
CN104136030B (zh) 2017-03-01
US9150544B2 (en) 2015-10-06
IL233238A0 (en) 2014-08-31
JP2015502382A (ja) 2015-01-22
RU2014129787A (ru) 2016-02-10
MX347620B (es) 2017-05-04
CN104136030A (zh) 2014-11-05
MX2014007671A (es) 2014-11-25
BR112014014869A2 (pt) 2017-06-13
EP2793887B1 (fr) 2015-10-21
SG11201403336QA (en) 2014-07-30
AU2012357123A1 (en) 2014-07-10
US20140329801A1 (en) 2014-11-06
TW201331195A (zh) 2013-08-01
EP2793887A1 (fr) 2014-10-29
AR089397A1 (es) 2014-08-20
JP6104936B2 (ja) 2017-03-29
KR20140106703A (ko) 2014-09-03

Similar Documents

Publication Publication Date Title
PL2768937T3 (pl) Preparaty, ich zastosowanie jako środków do mycia naczyń lub do wytwarzania środków do mycia naczyń i ich wytwarzanie
PH12014501702A1 (en) Imidazopyrrolidinone compounds
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
GB201118656D0 (en) New compounds
MX349004B (es) Nuevos compuestos.
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
CO6791606A2 (es) Composiciones y métodos para el tratamiento en aplicaciones clínicas de amplio espectro, no diferenciadas o combinadas
IN2014CN04861A (fr)
MY176987A (en) 2-substituted cephem compounds
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
EP2727614A4 (fr) Système de purification du sang
BR112013022052A2 (pt) ligantes antagonísticos de dr3
IN2015DN03998A (fr)
PL2841549T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
IN2014DN10449A (fr)
EP2825194A4 (fr) Utilisation d'antithrombine dans le traitement de la pré-éclampsie
IL236776A0 (en) Use of antithrombin in extracorporeal membrane oxidation
PH12014501176A1 (en) Anticoagulant reversal agents
DK2175877T3 (da) Anvendelse af muterede antitrombiner til behandling eller forebyggelse af koagulationssygdomme
UA117567C2 (uk) Композиція, яка стимулює лактацію, на основі фосфатидилсерину
AU2012307449A8 (en) Sulfonic acid salts of heterocyclylamide-substituted imidazoles